Log in to save to my catalogue

Should we screen blood products for hepatitis E virus RNA ?

Should we screen blood products for hepatitis E virus RNA ?

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1490901077

Should we screen blood products for hepatitis E virus RNA ?

About this item

Full title

Should we screen blood products for hepatitis E virus RNA ?

Publisher

England: Elsevier Ltd

Journal title

The Lancet (British edition), 2014-01, Vol.383 (9913), p.218-218

Language

English

Formats

Publication information

Publisher

England: Elsevier Ltd

More information

Scope and Contents

Contents

In view of the prevalence of hepatitis E infection in the general population (and therefore in potential blood donors) and the severe consequences of hepatitis E infection in immuno-compromised patients, we believe that systematic screening of blood products for markers of hepatitis E infection should be implemented in countries where hepatitis E i...

Alternative Titles

Full title

Should we screen blood products for hepatitis E virus RNA ?

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1490901077

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1490901077

Other Identifiers

ISSN

0140-6736

E-ISSN

1474-547X

DOI

10.1016/S0140-6736(14)60072-6

How to access this item